Monovision and multifocal IOLs offer excellent refractive outcomes

Article

Monovision correction and multifocal IOLs work well for correcting distance vision, with multifocal IOLs reducing the need for glasses but significantly increasing dysphotopsia for those who underwent implantation.

Monovision correction and multifocal IOLs work well for correcting distance vision, with multifocal IOLs reducing the need for glasses but significantly increasing dysphotopsia for those who underwent implantation. That’s the conclusion of research recently published in the Journal of Cataract & Refractive Surgery.

Investigators from Greece conducted a prospective randomized trial of 75 participants who had a diagnosis of senile cataract with stage 2 nuclear opalescence. Thirty-eight were assigned to the monovision group, and 37 were assigned to the multifocal IOL group. The researchers assessed uncorrected distance visual acuity (UDVA) and corrected distance visual acuity as well as Visual Function Index-14 (VF-14) scores and spectacle dependence, before surgery and 6 months afterward.

"Both techniques provided excellent refractive outcomes in UDVA and VF-14 scores," the researchers reported. Participants in the monovision group, however, demonstrated a greater need for glasses for near vision but experienced less glare than those in the multifocal group.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.